Peg10 Inhibitors refer to a diverse class of chemical compounds designed to target and modulate the activity of the PEG10 gene, primarily by interfering with its expression or function. PEG10, which stands for Paternally Expressed Gene 10, is a unique imprinted gene in mammals, implicated in various cellular processes, including cell proliferation, apoptosis, and cancer development. Inhibitors within this class act as valuable tools for researchers and scientists to investigate the intricate mechanisms through which PEG10 influences these processes. These compounds exhibit diverse chemical structures and mechanisms of action, enabling a comprehensive exploration of PEG10's roles in cellular biology.
The mechanisms by which Peg10 Inhibitors function can vary widely. Some compounds focus on epigenetic regulation, impacting PEG10 gene expression by targeting DNA methylation or histone modifications within its regulatory regions. Others may affect post-transcriptional processing, mRNA stability, or translation of PEG10 transcripts. Additionally, Peg10 Inhibitors can potentially interfere with the interactions between PEG10 and its downstream targets, inhibiting specific cellular pathways or signaling cascades associated with PEG10 function. By providing a suite of chemical tools to manipulate PEG10, this class of inhibitors empowers researchers to unravel the complex web of molecular events associated with PEG10's role in normal cellular physiology and disease states. Understanding the mechanisms and consequences of PEG10 inhibition can pave the way for new insights into the fundamental biology of this gene and its potential implications in various biological contexts.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $126.00 $278.00 $984.00 | 3 | |
La zébularine est un inhibiteur de l'ADN méthyltransférase qui empêche la méthylation de la région promotrice du PEG10, ce qui entraîne une réduction de l'expression du gène PEG10. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Cet inhibiteur, également connu sous le nom de Décitabine, agit de manière similaire à la Zébularine en inhibant les ADN méthyltransférases et en déméthylant le promoteur du PEG10. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 est une petite molécule inhibitrice des ADN méthyltransférases, y compris celles impliquées dans la méthylation du promoteur PEG10. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $63.00 $179.00 | 11 | |
Scriptaid est un inhibiteur d'histone désacétylase (HDAC) qui module la régulation épigénétique, affectant indirectement l'expression de PEG10. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Cet analogue de la cytidine s'incorpore dans l'ADN et inhibe les ADN-méthyltransférases, ce qui a un impact sur la méthylation du promoteur de PEG10. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
L'acide valproïque est un inhibiteur d'HDAC qui peut influencer l'expression du PEG10 en modifiant les schémas d'acétylation des histones. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
L'UNC0638 est un inhibiteur de l'histone méthyltransférase G9a, qui influence indirectement l'expression de PEG10 par le biais de modifications de la méthylation des histones. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EPZ-6438 est un inhibiteur de l'histone méthyltransférase EZH2 qui module l'expression du PEG10 en affectant les schémas de méthylation des histones. | ||||||